World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
83
Citations
27933
World Ranking
1430
National Ranking
728

Medicine

D-Index
86
Citations
30658
World Ranking
14013
National Ranking
7109

Bevra H. Hahn publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Bevra H. Hahn sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 322 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Bevra H. Hahn D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Bevra H. Hahn sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 83 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Bevra H. Hahn is affiliated with the University of California, Los Angeles in the United States. Their research is primarily concentrated in the fields of Medicine and Immunology and Microbiology, with a particular focus on systemic lupus erythematosus (SLE) and related immune system mechanisms.

The scientist's work spans multiple specialized areas including Immunology, Rheumatology, Oncology, Genetics, and Radiology, Nuclear Medicine and Imaging. Their research topics emphasize systemic lupus erythematosus research, cytokine signaling pathways and interactions, and T-cell and B-cell immunology. Additional focal points include atherosclerosis and cardiovascular diseases, immune cell function and interaction, monoclonal and polyclonal antibodies research, and chronic lymphocytic leukemia research.

Bevra H. Hahn has contributed to numerous publications across various reputable venues. Frequent journals where they have published include Frontiers in Immunology, Annals of the Rheumatic Diseases, Rheumatology and Immunology Research, The Journal of Rheumatology, and Arthritis & Rheumatology.

  • Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus (2022, Annals of the Rheumatic Diseases)
  • Interferon Genes Are Influenced by 17β-Estradiol in SLE (2021, Frontiers in Immunology)
  • Loss-of-function variants in SAT1 cause X-linked childhood-onset systemic lupus erythematosus (2022, Annals of the Rheumatic Diseases)
  • Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study (2021, The Journal of Rheumatology)
  • Suppression of Serum Interferon-γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus (2020, Arthritis & Rheumatology)

The scientist has collaborated frequently with several co-authors in their field. Notable collaborators include Ram P. Singh, David S. Bischoff, Ronald van Vollenhoven, Robert Gordon, and Loqmane Seridi.

Best Publications

  • 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Martin Aringer;Karen Costenbader;David Daikh;Ralph Brinks

  • Human polymorphism at microRNAs and microRNA target sites.

    Liuqing Yang;Chunru Lin;Chunyu Jin;Joy C. Yang

  • American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

    Bevra H. Hahn;Maureen A. McMahon;Alan Wilkinson;W. Dean Wallace

  • Combined oral contraceptives in women with systemic lupus erythematosus

    Michelle Petri;Mimi Y. Kim;Kenneth C. Kalunian;Jennifer Grossman

  • Antibodies to DNA

    Bevra Hannahs Hahn

  • The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: A randomized trial

    Jill P. Buyon;Michelle A. Petri;Mimi Y. Kim;Kenneth C. Kalunian

  • Association of increased interferon- inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus

    Xuebing Feng;Hui Wu;Jennifer M. Grossman;Punchong Hanvivadhanakul

  • A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis.

    Ellen M. Ginzler;Ellen M. Ginzler;Herbert S. Diamond;Max Weiner;Michael Schlesinger

  • Proinflammatory high‐density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis

    Maureen McMahon;Jennifer Grossman;John FitzGerald;Erika Dahlin-Lee

  • Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.

    Theodore J. Hahn;Linda R. Halstead;Steven L. Teitelbaum;Bevra H. Hahn

  • A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death

    Steven Rosner;Ellen M. Ginzler;Ellen M. Ginzler;Herbert S. Diamond;Max Weiner

  • The role of miRNA in inflammation and autoimmunity

    Ram Pyare Singh;Israel Massachi;Sudhir Manickavel;Satendra Singh

  • Guidelines for referral and management of systemic lupus erythematosus in adults

    Dafna D. Gladman;Murray B. Urowitz;John M. Esdaile;Bevra H. Hahn

  • Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

    Ronald F van Vollenhoven;Ronald F van Vollenhoven;Bevra H Hahn;George C Tsokos;Carrie L Wagner

  • Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Comparison of antibodies in serum and renal eluates.

    Fanny Ebling;Bevra H. Hahn

  • Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus.

    B P Tsao;R M Cantor;K C Kalunian;C J Chen

  • Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus

    Nan Shen;Qiong Fu;Qiong Fu;Yun Deng;Yun Deng;Xiaoxia Qian

  • The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia.

    Bevra H. Hahn;Jennifer Grossman;Weiling Chen;Maureen McMahon

  • Evaluation of factors associated with glucocorticoid‐induced osteopenia in patients with rheumatic diseases

    Thomas R. Dykman;Thomas R. Dykman;Oscar S. Gluck;Oscar S. Gluck;William A. Murphy;Theodore J. Hahn;Theodore J. Hahn

  • Th17 cells in inflammation and autoimmunity

    Ram Pyare Singh;Sascha Hasan;Sherven Sharma;Saranpreet Nagra

Frequent Co-Authors

Antonio La Cava
Antonio La Cava University of California, Los Angeles
Betty P. Tsao
Betty P. Tsao University of California, Los Angeles
Kenneth C. Kalunian
Kenneth C. Kalunian University of California, San Diego
Daniel J. Wallace
Daniel J. Wallace Cedars-Sinai Medical Center
John B. Harley
John B. Harley United States Department of Veterans Affairs
R. Hal Scofield
R. Hal Scofield University of Oklahoma Health Sciences Center
Rita M. Cantor
Rita M. Cantor University of California, Los Angeles
Kenneth M. Kaufman
Kenneth M. Kaufman Cincinnati Children's Hospital Medical Center
Rosalind Ramsey-Goldman
Rosalind Ramsey-Goldman Northwestern University
Judith A. James
Judith A. James Oklahoma Medical Research Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to various healthcare and research careers. For those interested in combining immunology knowledge with clinical practice, exploring nursing degrees can be a great pathway. Many students seek programs that balance accessibility and quality, such as the easiest lpn programs to get into, which provide foundational nursing education with manageable entry requirements.

For advanced clinical roles, becoming a Nurse Practitioner (NP) is a popular choice. Prospective students can find the easiest np programs to get into that offer streamlined admission processes without compromising on education quality. This can be especially beneficial when advancing immunology-related expertise in patient care.

Mental health is an important aspect where immunology intersects with psychiatric care. Online programs like the best online psychiatric mental health nurse practitioner programs provide excellent clinical placement opportunities, allowing students to gain hands-on experience in this specialized field.

For those mindful of budget constraints, affordable options such as the cheapest pmhnp certificate programs can make advanced nursing education in psychiatric mental health more accessible. These pathways combine cost-effectiveness with quality training for future healthcare professionals.

Best Scientists Citing Bevra H. Hahn

Trending Scientists

Recently Published Articles